Mukaltin (Mucaltin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Active ingredient:

Mukaltin

(Althea medicinal herb extract)

the extract is dry with a content of reducing monosaccharides of at least 8.0% and a polysaccharide complex of at least 50.0%

0.05 g

Excipients:

Sodium bicarbonate

0.087 g

Wine acid

0.160 g

Calcium stearate

0.003 grams

Weight of a tablet

0.300 grams
Description:

Tablets are round, flat-cylindrical, with a facet and a risk, from light gray to brownish-gray with darker and lighter blotches, with a weak characteristic odor.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
    • Pharmacodynamics:

    Mucaltin contains a mixture of polysaccharides from the herb althea medicinal. Possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.

    Indications:

    Acute and chronic diseases of the respiratory system, accompanied by the formation of difficult-to-detachable sputum of increased viscosity (tracheobronchitis, chronic obstructive pulmonary disease, bronchiectatic disease, pneumonia, pulmonary emphysema, pneumoconiosis) - as part of complex therapy.

    Contraindications:

    Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years.

    Pregnancy and lactation:

    Taking the drug during pregnancy and during breastfeeding is possible on the recommendation of a doctor.

    Dosing and Administration:

    Inside, 1-2 tablets 2-3 times a day before eating.

    Children can dissolve the pill in 1/3 cup of warm water.

    The course of treatment is 7-14 days.

    Side effects:

    Allergic reactions are possible; rarely - dyspeptic phenomena.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    The drug can be administered concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    The drug should not be used concomitantly with preparations containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work).

    Form release / dosage:Tablets, 50 mg.
    Packaging:

    For 10 tablets in a contiguous cell-free or cell pack.

    200 contour non-junction or cell packs together with an equal number of instructions for use are placed in a box or in a box of cardboard.

    Storage conditions:

    In a dry place, at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000800
    Date of registration:30.12.2011 / 01.11.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp18.05.2018
    Illustrated instructions
      Instructions
      Up